The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant tislelizumab plus nab-paclitaxel and carboplatin followed by adjuvant tislelizumab in patients with early triple-negative breast cancer.
 
Zefei Jiang
No Relationships to Disclose
 
Zhigang Yu
No Relationships to Disclose
 
Cuizhi Geng
No Relationships to Disclose
 
Ying Lin
No Relationships to Disclose
 
Zhenzhen Liu
No Relationships to Disclose
 
Peifen Fu
No Relationships to Disclose
 
Qiang Liu
Consulting or Advisory Role - AstraZeneca; Novartis
Speakers' Bureau - AstraZeneca; Eisai; Novartis; Pfizer; Roche
Research Funding - Eisai